Secondary analysis of SPRINTT (1506 older adults): a lifestyle intervention did not significantly reduce mobility disability in benzodiazepine users (HR 1.04) or non-users (HR 0.86); in those with SPPB 3–7, benefit was seen only in non-users (HR 0.80; interaction P=.035).
Secondary analysisn = 1,506
Levati et al. Does the use of benzodiazepine influence the effectiveness of lifestyle intervention? Secondary analysis from the Sarcopenia and Physical fRailty iN older people strategies (SPRINTT) trial